Related Experiment Video
Updated: Nov 23, 2025

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence
Published on: January 7, 2019
Expression and Clinical Significance of ANXA1 and DICER1 in Myelodysplastic Syndromes
Wenqi Wu1, Chengyao Wan1, Qiongni Xie1
1Department of Hematology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.
Insights
Expression of ANXA1 and DICER1 is decreased in myelodysplastic syndromes (MDS). ANXA1 may predict leukemia transformation, while DICER1 shows diagnostic significance for MDS.
Area of Science:
- Hematology
- Molecular Biology
- Oncology
Background:
- Myelodysplastic syndromes (MDS) are a group of clonal hematopoietic stem cell disorders.
- Understanding molecular markers in MDS is crucial for diagnosis and prognosis.
Purpose of the Study:
- To investigate the expression levels of ANXA1 and DICER1 in MDS patients.
- To determine the clinical significance of ANXA1 and DICER1 in MDS and their correlation with disease progression and outcomes.
Main Methods:
- A case-control study involving 49 MDS patients and 12 healthy volunteers.
- Quantitative real-time fluorescence PCR (qRT-PCR) was used to measure ANXA1 and DICER1 expression in bone marrow.
- Correlation analysis between gene expression and clinical parameters was performed.
Main Results:
- ANXA1 and DICER1 expression were significantly lower in MDS patients compared to controls.
- Down-expression of ANXA1 helped differentiate secondary acute myeloid leukemia (s-AML) from MDS.
- DICER1 expression effectively screened MDS patients from healthy individuals.
- ANXA1 expression negatively correlated with bone marrow blast percentage, IPSS, and WHO subtypes.
Conclusions:
- Bone marrow ANXA1 may serve as a biomarker for predicting leukemia transformation risk in MDS.
- DICER1 expression holds diagnostic significance for MDS.
- These findings highlight potential roles for ANXA1 and DICER1 in MDS management.
Objective:
To explore the expression status of ANXA1 and DICER1 and their clinical significance in myelodysplastic syndromes (MDS) patients. Study Design: A case control study.
Place And Duration Of Study:
Department of Hematology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China, from January 2011 to June 2020.
Methodology:
Quantitative real-time fluorescence PCR (qRT-PCR) was carried out to detect ANXA1 and DICER1 expression levels in the bone marrow from 49 MDS patients and 12 healthy volunteers as control. The correlation of the clinical parameters and ANXA1 or DICER1 expression was then analysed in MDS.
Results:
Compared with normal controls, the expression of bone marrow ANXA1 and DICER1 in MDS patients was significantly decreased, especially in patients with secondary acute myeloid leukemia (s-AML). Moreover, down-expression of ANXA1 had a great effect on differentiating s-AML subjects from MDS cases, and DICER1 expression showed good performance to screen MDS subjects from normal controls. ANXA1 expression was negatively correlated with clinical features of poor prognosis such as the percentage of bone marrow blasts, IPSS and WHO subtypes.
Conclusions:
Bone marrow ANXA1 may be a potential biomarker for the risk prediction of leukemia transformation in MDS. DICER1 may have diagnostic significance to MDS. Key Words: Myelodysplastic syndrome, Secondary acute myeloid leukemia, ANXA1, DICER1.
More Related Videos
10:21Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
Published on: February 21, 2018
11:06Genome-wide Analysis of HDAC Inhibitor-mediated Modulation of microRNAs and mRNAs in B Cells Induced to Undergo Class-switch DNA Recombination and Plasma Cell Differentiation
Published on: September 20, 2017
Related Concept Videos
Abnormal Proliferation
Exon Recombination
Exon shuffling follows “splice frame rules.” Each exon...
Master Transcription Regulators
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...